The network of pluripotency, epithelial–mesenchymal transition, and prognosis of breast cancer

References

• SørlieTPerouCMTibshiraniRGene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProc Natl Acad Sci U S A20019819108691087411553815
   PubMed Web of Science ®Google Scholar
• KenneckeHYerushalmiRWoodsRMetastatic behavior of breast cancer subtypesJ Clin Oncol201028203271327720498394
   PubMed Web of Science ®Google Scholar
• CareyLADeesECSawyerLThe triple negative paradox: primary tumor chemosensitivity of breast cancer subtypesClin Cancer Res20071382329233417438091
   PubMed Web of Science ®Google Scholar
• PratAParkerJSFanCConcordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifenAnn Oncol201223112866287322532584
   PubMed Web of Science ®Google Scholar
• SimonsBDCleversHStrategies for homeostatic stem cell self-renewal in adult tissuesCell2011145685186221663791
   PubMed Web of Science ®Google Scholar
• VilladsenRFridriksdottirAJRønnov-JessenLEvidence for a stem cell hierarchy in the adult human breastJ Cell Biol200717718710117420292
   PubMed Web of Science ®Google Scholar
• Al-HajjMWichaMSBenito-HernandezAMorrisonSJClarkeMFProspective identification of tumorigenic breast cancer cellsProc Natl Acad Sci U S A200310073983398812629218
   PubMed Web of Science ®Google Scholar
• GinestierCHurMHCharafe-JauffretEALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcomeCell Stem Cell200715155556718371393
   PubMedGoogle Scholar
• InceTARichardsonALBellGWTransformation of different human breast epithelial cell types leads to distinct tumor phenotypesCancer Cell200712216017017692807
   PubMed Web of Science ®Google Scholar
• HonethGBendahlPORingnérMThe CD44+/CD24− phenotype is enriched in basal-like breast tumorsBreast Cancer Res200810R5318559090
   PubMed Web of Science ®Google Scholar
• HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
   PubMed Web of Science ®Google Scholar
• TakahashiKYamanakaSInduction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factorsCell2006126466367616904174
   PubMed Web of Science ®Google Scholar
• YuJVodyanikMASmuga-OttoKInduced pluripotent stem cell lines derived from human somatic cellsScience200731858581917192018029452
   PubMed Web of Science ®Google Scholar
• MarsonALevineSSColeMFConnecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cellsCell2008134352153318692474
   PubMed Web of Science ®Google Scholar
• MicalizziDSFarabaughSMFordHLEpithelial-mesenchymal transition in cancer: parallels between normal development and tumor progressionJ Mammary Gland Biol Neoplasia201015211713420490631
   PubMed Web of Science ®Google Scholar
• ManiSAGuoWLiaoMJThe epithelial-mesenchymal transition generates cells with properties of stem cellsCell2008133470471518485877
   PubMed Web of Science ®Google Scholar
• MorelAPLièvreMThomasCHinkalGAnsieauSPuisieuxAGeneration of breast cancer stem cells through epithelial-mesenchymal transitionPLoS One200838e288818682804
   PubMed Web of Science ®Google Scholar
• Anokye-DansoFTrivediCMJuhrDHighly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotencyCell Stem Cell20118437638821474102
   PubMed Web of Science ®Google Scholar
• NicholsJZevnikBAnastassiadisKFormation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4Cell19989533793919814708
   PubMed Web of Science ®Google Scholar
• StefanovicSPucéatMThe dual role of OCT4Med Sci (Paris)2010264411416 French20412747
   PubMedGoogle Scholar
• KehlerJTolkunovaEKoschorzBOct4 is required for primordial germ cell survivalEMBO Rep20045111078108315486564
   PubMed Web of Science ®Google Scholar
• StefanovicSAbboudNDésiletsSNuryDCowanCPucéatMInterplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fateJ Cell Biol2009186566567319736317
   PubMed Web of Science ®Google Scholar
• Deb-RinkerPLyDJezierskiASikorskaMWalkerPRSequential DNA methylation of the Nanog and Oct-4 upstream regions in human NT2 cells during neuronal differentiationJ Biol Chem200528086257626015615706
   PubMed Web of Science ®Google Scholar
• LinYYangYLiWReciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cellsMol Cell201248462764023041284
   PubMed Web of Science ®Google Scholar
• HassiotouFHepworthARBeltranASExpression of the pluripotency transcription factor OCT4 in the normal and aberrant mammary glandFront Oncol201337923596564
   PubMedGoogle Scholar
• SarkarAHochedlingerKThe sox family of transcription factors: versatile regulators of stem and progenitor cell fateCell Stem Cell2013121153023290134
   PubMed Web of Science ®Google Scholar
• LiuKLinBZhaoMThe multiple roles for Sox2 in stem cell maintenance and tumorigenesisCell Signal20132551264127123416461
   PubMed Web of Science ®Google Scholar
• WeinaKUtikalJSOX2 and cancer: current research and its implications in the clinicClin Transl Med201431925114775
   PubMedGoogle Scholar
• RizzinoAConcise review: the Sox2-Oct4 connection: critical players in a much larger interdependent network integrated at multiple levelsStem Cells20133161033103923401375
   PubMed Web of Science ®Google Scholar
• BoyerLALeeTIColeMFCore transcriptional regulatory circuitry in human embryonic stem cellsCell2005122694795616153702
   PubMed Web of Science ®Google Scholar
• ChenXXuHYuanPIntegration of external signaling pathways with the core transcriptional network in embryonic stem cellsCell200813361106111718555785
   PubMed Web of Science ®Google Scholar
• LiangSFuruhashiMNakaneRIsolation and characterization of human breast cancer cells with SOX2 promoter activityBiochem Biophys Res Commun2013437220521123796710
   PubMed Web of Science ®Google Scholar
• LeisOEguiaraALopez-ArribillagaESox2 expression in breast tumours and activation in breast cancer stem cellsOncogene201231111354136521822303
   PubMed Web of Science ®Google Scholar
• LengerkeCFehmTKurthRExpression of the embryonic stem cell marker SOX2 in early-stage breast carcinomaBMC Cancer2011114221276239
   PubMed Web of Science ®Google Scholar
• TheunissenTWSilvaJCSwitching on pluripotency: a perspective on the biological requirement of NanogPhilos Trans R Soc Lond B Biol Sci201136615752222222921727127
   PubMed Web of Science ®Google Scholar
• WangMLChiouSHWuCWTargeting cancer stem cells: emerging role of Nanog transcription factorOnco Targets Ther201361207122024043946
   PubMed Web of Science ®Google Scholar
• SilvaJNicholsJTheunissenTWNanog is the gateway to the pluripotent ground stateCell2009138472273719703398
   PubMed Web of Science ®Google Scholar
• NavarroPAvnerPWhen X-inactivation meets pluripotency: an intimate rendezvousFEBS Lett2009583111721172719327353
   PubMed Web of Science ®Google Scholar
• ShiGJinYRole of Oct4 in maintaining and regaining stem cell pluripotencyStem Cell Res Ther2010153921156086
   PubMed Web of Science ®Google Scholar
• LuXMazurSJLinTAppellaEXuYThe pluripotency factor nanog promotes breast cancer tumorigenesis and metastasisOncogene201433202655266423770853
   PubMed Web of Science ®Google Scholar
• LiaoWYLiawCCHuangYCCyclohexylmethyl flavonoids suppress propagation of breast cancer stem cells via downregulation of NANOGEvid Based Complement Alternat Med2013201317026123662114
   PubMed Web of Science ®Google Scholar
• LingGQChenDBWangBQZhangLSExpression of the pluripotency markers Oct3/4, Nanog and Sox2 in human breast cancer cell linesOncol Lett2012461264126823197999
   PubMed Web of Science ®Google Scholar
• JeterCRBadeauxMChoyGFunctional evidence that the self-renewal gene NANOG regulates human tumor developmentStem Cells2009275993100519415763
   PubMed Web of Science ®Google Scholar
• EzehUITurekPJReijoRAClarkATHuman embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinomaCancer2005104102255226516228988
   PubMed Web of Science ®Google Scholar
• DangCVMYC on the path to cancerCell20121491223522464321
   PubMed Web of Science ®Google Scholar
• TakahashiKTanabeKOhnukiMInduction of pluripotent stem cells from adult human fibroblasts by defined factorsCell2007131586187218035408
   PubMed Web of Science ®Google Scholar
• KnoepflerPSWhy myc? An unexpected ingredient in the stem cell cocktailCell Stem Cell200821182118371417
   PubMed Web of Science ®Google Scholar
• SodirNMEvanGINursing some sense out of MycJ Biol200987719804609
   PubMedGoogle Scholar
• StoelzleTSchwarbPTrumppAHynesNEc-Myc affects mRNA translation, cell proliferation and progenitor cell function in the mammary glandBMC Biol200976319785743
   PubMed Web of Science ®Google Scholar
• XuJChenYOlopadeOIMYC and breast cancerGenes Cancer20101662964021779462
   PubMedGoogle Scholar
• CowlingVHD’CruzCMChodoshLAColeMDc-Myc transforms human mammary epithelial cells through repression of the Wnt inhibitors DKK1 and SFRP1Mol Cell Biol200727145135514617485441
   PubMed Web of Science ®Google Scholar
• ElkakAEMeligonisGSalhabMhTERT protein expression is independent of clinicopathological parameters and c-Myc protein expression in human breast cancerJ Carcinog200541716202165
   PubMedGoogle Scholar
• DueckACReinholzMMGeigerXJImpact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831Clin Cancer Res201319205798580723965903
   PubMed Web of Science ®Google Scholar
• GhalebAMYangVWThe pathobiology of Krüppel-like factors in colorectal cancerCurr Colorectal Cancer Rep200842596418504508
   PubMedGoogle Scholar
• YuFLiJChenHKruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasionOncogene201130182161217221242971
   PubMed Web of Science ®Google Scholar
• YuFShiYWangJLiJFanDAiWDeficiency of Kruppel-like factor KLF4 in mammary tumor cells inhibits tumor growth and pulmonary metastasis and is accompanied by compromised recruitment of myeloid-derived suppressor cellsInt J Cancer2013133122872288323737434
   PubMed Web of Science ®Google Scholar
• ThorntonJEGregoryRIHow does Lin28 let-7 control development and disease?Trends Cell Biol201222947448222784697
   PubMed Web of Science ®Google Scholar
• JohnsonSMGrosshansHShingaraJRAS is regulated by the let-7 microRNA familyCell2005120563564715766527
   PubMed Web of Science ®Google Scholar
• CaiWYWeiTZLuoQCThe Wnt-β-catenin pathway represses let-7 microRNA expression through transactivation of Lin28 to augment breast cancer stem cell expansionJ Cell Sci2013126Pt 132877288923613467
   PubMed Web of Science ®Google Scholar
• PiskounovaEPolytarchouCThorntonJELin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanismsCell201114751066107922118463
   PubMed Web of Science ®Google Scholar
• SvobodaPFlemrMThe role of miRNAs and endogenous siRNAs in maternal-to-zygotic reprogramming and the establishment of pluripotencyEMBO Rep201011859059720651740
   PubMed Web of Science ®Google Scholar
• LiuHDengSZhaoZOct4 regulates the miR-302 cluster in P19 mouse embryonic carcinoma cellsMol Biol Rep20113832155216020857206
   PubMed Web of Science ®Google Scholar
• JudsonRLBabiarzJVenereMBlellochREmbryonic stem cell-specific microRNAs promote induced pluripotencyNat Biotechnol200927545946119363475
   PubMed Web of Science ®Google Scholar
• LiangZAhnJGuoDVotawJRShimHMicroRNA-302 replacement therapy sensitizes breast cancer cells to ionizing radiationPharm Res20133041008101623184229
   PubMed Web of Science ®Google Scholar
• BourguignonLYWongGEarleCChenLHyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinomaJ Biol Chem201228739328003282422847005
   PubMed Web of Science ®Google Scholar
• O’DonnellKAWentzelFAZellerKIDangCVMendellJTC-Myc-regulated microRNAs modulate E2F1 expressionNature2005435704383984315944709
   PubMed Web of Science ®Google Scholar
• MogilyanskyERigoutsosIThe miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and diseaseCell Death Differ201320121603161424212931
   PubMed Web of Science ®Google Scholar
• SmithALIwanagaRDrasinDJThe miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancerOncogene201231505162517122286770
   PubMed Web of Science ®Google Scholar
• FaraziTAHorlingsHMTen HoeveJJMicroRNA sequence and expression analysis in breast tumors by deep sequencingCancer Res201171134443445321586611
   PubMed Web of Science ®Google Scholar
• LeivonenSKMäkeläROstlingPProtein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell linesOncogene200928443926393619684618
   PubMed Web of Science ®Google Scholar
• NiwaHMiyazakiJSmithAGQuantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cellsNat Genet200024437237610742100
   PubMed Web of Science ®Google Scholar
• ThieryJPSleemanJPComplex networks orchestrate epithelial-mesenchymal transitionsNat Rev Mol Cell Biol20067213114216493418
   PubMed Web of Science ®Google Scholar
• VoutsadakisIAThe ubiquitin-proteasome system and signal transduction pathways regulating epithelial mesenchymal transition of cancerJ Biomed Sci2012196722827778
   PubMed Web of Science ®Google Scholar
• ZeisbergMNeilsonEGBiomarkers for epithelial-mesenchymal transitionsJ Clin Invest200911961429143719487819
   PubMed Web of Science ®Google Scholar
• GuoFParker KerriganBCYangDPost-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitionsJ Hematol Oncol201471924598126
   PubMed Web of Science ®Google Scholar
• TaylorMAParvaniJGSchiemannWPThe pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cellsJ Mammary Gland Biol Neoplasia201015216919020467795
   PubMed Web of Science ®Google Scholar
• DhasarathyAPhadkeDMavDShahRRWadePAThe transcription factors Snail and Slug activate the transforming growth factor-beta signaling pathway in breast cancerPLoS One2011610e2651422028892
   PubMed Web of Science ®Google Scholar
• TiwariNTiwariVKWaldmeierLSox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogrammingCancer Cell201323676878323764001
   PubMed Web of Science ®Google Scholar
• TranDDCorsaCABiswasHAftRLLongmoreGDTemporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrenceMol Cancer Res20119121644165722006115
   PubMed Web of Science ®Google Scholar
• de HerrerosAGPeiróSNassourMSavagnerPSnail family regulation and epithelial mesenchymal transitions in breast cancer progressionJ Mammary Gland Biol Neoplasia201015213514720455012
   PubMed Web of Science ®Google Scholar
• ProiaTAKellerPJGuptaPBGenetic predisposition directs breast cancer phenotype by dictating progenitor cell fateCell Stem Cell20118214916321295272
   PubMed Web of Science ®Google Scholar
• FoubertEDe CraeneBBerxGKey signalling nodes in mammary gland development and cancer. The Snail1-Twist1 conspiracy in malignant breast cancer progressionBreast Cancer Res20101220620594364
   PubMed Web of Science ®Google Scholar
• LeeKAGjorevskiNBoghaertERadiskyDCNelsonCMSnail1, Snail2, and E47 promote mammary epithelial branching morphogenesisEMBO J201130132662267421610693
   PubMed Web of Science ®Google Scholar
• GrasBJacqueroudLWierinckxASnail family members unequally trigger EMT and thereby differ in their ability to promote the neoplastic transformation of mammary epithelial cellsPLoS One201493e9225424638100
   PubMed Web of Science ®Google Scholar
• ZhangAWangQHanZReduced expression of Snail decreases breast cancer cell motility by downregulating the expression and inhibiting the activity of RhoA GTPaseOncol Lett20136233934624137327
   PubMed Web of Science ®Google Scholar
• OkuboTTruongTKYuBDown-regulation of promoter 1.3 activity of the human aromatase gene in breast tissue by zinc-finger protein, Snail (SnaH)Cancer Res20016141338134611245431
   PubMed Web of Science ®Google Scholar
• MartinTAGoyalAWatkinsGJiangWGExpression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancerAnn Surg Oncol200512648849615864483
   PubMed Web of Science ®Google Scholar
• MuenstSDästerSObermannECNuclear expression of snail is an independent negative prognostic factor in human breast cancerDis Markers201335533734424191127
   PubMedGoogle Scholar
• HillLBrowneGTulchinskyEZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancerInt J Cancer2013132474575422753312
   PubMed Web of Science ®Google Scholar
• WangGGuoXHongWCritical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generationProc Natl Acad Sci U S A201311082858286323386720
   PubMed Web of Science ®Google Scholar
• KorpalMEllBJBuffaFMDirect targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonizationNat Med20121791101110821822286
   PubMed Web of Science ®Google Scholar
• Kasimir-BauerSHoffmannOWallwienerDKimmigRFehmTExpression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cellsBreast Cancer Res201214R1522264265
   PubMed Web of Science ®Google Scholar
• van NesJGde KruijfEMPutterHCo-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patientsBreast Cancer Res Treat20121331495921796367
   PubMed Web of Science ®Google Scholar
• CubilloEDiaz-LopezACuevasEPE47 and Id1 interplay in epithelial-mesenchymal transitionPLoS One201383e5994823555842
   PubMed Web of Science ®Google Scholar
• PerkJGil-BazoIChinYReassessment of id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-id1 antibodyCancer Res20066622108701087717108123
   PubMed Web of Science ®Google Scholar
• NassourMIdoux-GilletYSelmiASlug controls stem/progenitor cell growth dynamics during mammary gland morphogenesisPLoS One2012712e5349823300933
   PubMed Web of Science ®Google Scholar
• FangXCaiYLiuJTwist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and stem-like cell self-renewalOncogene201130474707472021602879
   PubMed Web of Science ®Google Scholar
• VesunaFLisokAKimbleBRamanVTwist modulates breast cancer stem cells by transcriptional regulation of CD24 expressionNeoplasia200911121318132820019840
   PubMed Web of Science ®Google Scholar
• YangMHHsuDSWangHWBmi1 is essential in Twist1-induced epithelial-mesenchymal transitionNat Cell Biol2010121098299220818389
   PubMed Web of Science ®Google Scholar
• WangDLuPZhangHOct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patientsOncotarget2014521108031081525301732
   PubMedGoogle Scholar
• LiRLiangJNiSA mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblastsCell Stem Cell201071516320621050
   PubMed Web of Science ®Google Scholar
• YinLCastagninoPAssoianRKABCG2 expression and side population abundance regulated by a transforming growth factor beta-directed epithelial-mesenchymal transitionCancer Res200868380080718245481
   PubMed Web of Science ®Google Scholar
• MalliniPLennardTKirbyJMeesonAEpithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistanceCancer Treat Rev20144034134824090504
   PubMed Web of Science ®Google Scholar
• TangBYooNVuMTransforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft modelCancer Res200767188643865217875704
   PubMed Web of Science ®Google Scholar
• YoriJLJohnsonEZhouGJainMKKeriRAKruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expressionJ Biol Chem201028522168541686320356845
   PubMed Web of Science ®Google Scholar
• KoopmanschBBerxGFoidartJMGillesCWinklerRInterplay between KLF4 and ZEB2/SIP1 in the regulation of E-cadherin expressionBiochem Biophys Res Commun2013431465265723376074
   PubMed Web of Science ®Google Scholar
• AkaogiKNakajimaYItoIKLF4 suppresses estrogen- dependent breast cancer growth by inhibiting the transcriptional activity of ERalphaOncogene200928322894290219503094
   PubMed Web of Science ®Google Scholar
• HuDZhouZDavidsonNEHuangYWanYNovel insight into KLF4 proteolytic regulation in estrogen receptor signaling and breast carcinogenesisJ Biol Chem201228717135841359722389506
   PubMed Web of Science ®Google Scholar
• LiuYLiHFengJLin28 induces epithelial-to-mesenchymal transition and stemness via downregulation of let-7a in breast cancer cellsPLoS One2013812e8308324349438
   PubMed Web of Science ®Google Scholar
• LiaoBBaoXLiuLMicroRNA cluster 302–367 enhances somatic cell reprogramming by accelerating a mesenchymal-to-epithelial transitionJ Biol Chem201128619173591736421454525
   PubMed Web of Science ®Google Scholar
• SubramanyamDLamouilleSJudsonRLMultiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cellsNat Biotechnol201129544344821490602
   PubMed Web of Science ®Google Scholar
• ManiSAYangJBrooksMMesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancersProc Natl Acad Sci U S A200710424100691007417537911
   PubMed Web of Science ®Google Scholar
• HollierBGTinnirelloAAWerdenSJFOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancerCancer Res20137361981199223378344
   PubMed Web of Science ®Google Scholar
• ChimgeNOBaniwalSKLittleGHRegulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2Breast Cancer Res201113R12722151997
   PubMed Web of Science ®Google Scholar
• HongSHNahHYLeeYJExpression of estrogen receptor-alpha and -beta, glucocorticoid receptor, and progesterone receptor genes in human embryonic stem cells and embryoid bodiesMol Cells200418332032515650328
   PubMed Web of Science ®Google Scholar
• HorwitzKBDyeWWHarrellJCKabosPSartoriusCARare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenograftsProc Natl Acad Sci U S A2008105155774577918391223
   PubMed Web of Science ®Google Scholar
• KabosPHaughianJMWangXCytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancersBreast Cancer Res Treat20111281455520665103
   PubMed Web of Science ®Google Scholar
• LiXChenSSunTThe transcriptional regulation of SOX2 on FOXA1 gene and its application in diagnosis of human breast and lung cancersClin Lab201460690991825016694
   PubMed Web of Science ®Google Scholar
• BernardoGMKeriRAFOXA1: a transcription factor with parallel functions in development and cancerBiosci Rep201232211313022115363
   PubMed Web of Science ®Google Scholar
• LiuYNLeeWWWangCYChaoTHChenYChenJHRegulatory mechanisms controlling human E-cadherin gene expressionOncogene200524568277829016116478
   PubMed Web of Science ®Google Scholar
• JungJWParkSBLeeSJSeoMSTroskoJEKangKSMetformin represses self-renewal of the human breast carcinoma stem cells via inhibition of estrogen receptor-mediated OCT4 expressionPLoS One2011611e2806822132214
   PubMed Web of Science ®Google Scholar
• SimõesBMPivaMIriondoOEffects of estrogen on the proportion of stem cells in the breastBreast Cancer Res Treat20111291233520859678
   PubMed Web of Science ®Google Scholar
• FillmoreCMGuptaPBRudnickJAEstrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signalingProc Natl Acad Sci U S A201010750217372174221098263
   PubMed Web of Science ®Google Scholar
• HiscoxSJiangWGObermeierKTamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylationInt J Cancer2006118229030116080193
   PubMed Web of Science ®Google Scholar
• Asselin-LabatMLVaillantFSheridanJMControl of mammary stem cell function by steroid hormone signallingNature2010465729979880220383121
   PubMed Web of Science ®Google Scholar
• JoshiPAJacksonHWBeristainAGProgesterone induces adult mammary stem cell expansionNature2010465729980380720445538
   PubMed Web of Science ®Google Scholar
• Al SalehSAl MullaFLuqmaniYAEstrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cellsPLoS One201166e2061021713035
   PubMed Web of Science ®Google Scholar
• ArteagaCLTandonAKVon HoffDDOsborneCKTransforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cellsCancer Res198848389839043164252
   PubMed Web of Science ®Google Scholar
• ShipitsinMCampbellLLArganiPMolecular definition of breast tumor heterogeneityCancer Cell20071125927317349583
   PubMed Web of Science ®Google Scholar
• VesunaFLisokAKimbleBTwist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-αOncogene20123127322233234
   Web of Science ®Google Scholar
• LapidusRGFergusonATOttavianoYLMethylation of estrogen receptor gene 5′ CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumorsClin Cancer Res1996258058109816234
   PubMed Web of Science ®Google Scholar
• SunYWangYFanCEstrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activationMol Cancer20141313724889938
   PubMed Web of Science ®Google Scholar
• SoaresRBaloghGGuoSGärtnerFRussoJSchmittFEvidence for the notch signaling pathway on the role of estrogen in angiogenesisMol Endocrinol2004182333234315192074
   PubMedGoogle Scholar
• D’AngeloRCOuzounovaMDavisANotch reporter activity in breast cancer cell lines identifies a subset of cells with stem cell activityMol Cancer Ther201514377978725673823
   PubMed Web of Science ®Google Scholar
• WangHLiuHLiXEstrogen receptor α-coupled Bmi1 regulation pathway in breast cancer and its clinical implicationsBMC Cancer20141412224559156
   PubMed Web of Science ®Google Scholar
• XuNPapagiannakopoulosTPanGThomsonJAKosikKSMicroR-NA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cellsCell2009137464765819409607
   PubMed Web of Science ®Google Scholar
• GodarSInceTABellGWGrowth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expressionCell20081341627318614011
   PubMed Web of Science ®Google Scholar
• HermekingHMicroRNAs in thep53 network: micromanagement of tumour suppressionNat Rev Cancer201212961362622898542
   PubMed Web of Science ®Google Scholar
• RieberMStrasberg-RieberMp53 inactivation decreases dependence on estrogen/ERK signalling for proliferation but promotes EMT and susceptibility to 3-bromopyruvate in ERα+ breast cancer MCF-7 cellsBiochem Pharmacol201488216917724486524
   PubMed Web of Science ®Google Scholar
• ZhangYYanWChenXMutant p53 disrupts MCF-10A cell polarity in three-dimensional culture via epithelial-to-mesenchymal transitionsJ Biol Chem201128618162181622821454711
   PubMed Web of Science ®Google Scholar
• WeiszLDamalasALiontosMMutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cellsCancer Res20076762396240117363555
   PubMed Web of Science ®Google Scholar
• SchramekDLeibbrandtASiglVOsteoclast differentiation factor RANKL controls development of progestin-driven mammary cancerNature201046873209810220881962
   PubMed Web of Science ®Google Scholar
• LiuMSakamakiTCasimiroMCThe canonical NF-kappaB pathway governs mammary tumorigenesis in transgenic mice and tumor stem cell expansionCancer Res20107024104641047321159656
   PubMed Web of Science ®Google Scholar
• TsubakiMKomaiMFujimotoSActivation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell linesJ Exp Clin Cancer Res2013326224011086
   PubMed Web of Science ®Google Scholar
• BertheauPLehmann-CheJVarnaMp53 in breast cancer subtypes and new insights into response to chemotherapyBreast201322Suppl 2S27S2924074787
   PubMedGoogle Scholar
• DaiCGuWp53 post-translational modification: deregulated in tumorigenesisTrends Mol Med2010161152853520932800
   PubMed Web of Science ®Google Scholar
• MimotoRTairaNTakahashiHDYRK2 controls the epithelial-mesenchymal transition in breast cancer by degrading SnailCancer Lett2013339221422523791882
   PubMed Web of Science ®Google Scholar
• LiuTSunBZhaoXOCT4 expression and vasculogenic mimicry formation positively correlate with poor prognosis in human breast cancerInt J Mol Sci20141511196341964925353179
   PubMed Web of Science ®Google Scholar
• PivaMDomeniciGIriondoOSox2 promotes tamoxifen resistance in breast cancer cellsEMBO Mol Med201461667924178749
   PubMed Web of Science ®Google Scholar
• FinicelliMBenedettiGSquillaroTExpression of stemness genes in primary breast cancer tissues: the role of SOX2 as a prognostic marker for detection of early recurrenceOncotarget20145209678968825127259
   PubMedGoogle Scholar
• HuangYHLuoMHNiYBIncreased SOX2 expression in less differentiated breast carcinomas and their lymph node metastasesHistopathology201464449450324382260
   PubMed Web of Science ®Google Scholar
• NagataTShimadaYSekineSPrognostic significance of NANOG and KLF4 for breast cancerBreast Cancer20142119610122528804
   PubMed Web of Science ®Google Scholar
• PandyaAYTalleyLIFrostARNuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancerClin Cancer Res20041082709271915102675
   PubMed Web of Science ®Google Scholar
• PietiläinenTLipponenPAaltomaaSEskelinenMKosmaVMSyrjänenKExpression of c-myc proteins in breast cancer as related to established prognostic factors and survivalAnticancer Res19951539599647645986
   PubMed Web of Science ®Google Scholar
• DueckACReinholzMMGeigerXJImpact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831Clin Cancer Res201319205798580723965903
   PubMed Web of Science ®Google Scholar
• RenJJinFYuZMYC overexpression and poor prognosis in sporadic breast cancer with BRCA1 deficiencyTumour Biol20133463945395823860775
   PubMedGoogle Scholar
• SchlotterCMVogtUBosseUMerschBWassmannKC-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancerBreast Cancer Res200352R30R3612631396
   PubMed Web of Science ®Google Scholar
• Rodriguez-PinillaSMJonesRLLambrosMBMYC amplification in breast cancer: a chromogenic in situ hybridisation studyJ Clin Pathol20076091017102317158641
   PubMed Web of Science ®Google Scholar
• FengCNeumeisterVMaWLin28 regulates HER2 and promotes malignancy through multiple mechanismsCell Cycle201211132486249422713243
   PubMed Web of Science ®Google Scholar
• XieRWangYNieWLin28B expression correlates with aggressive clinicopathological characteristics in breast invasive ductal carcinomaCancer Biother Radiopharm201429521522024885919
   PubMed Web of Science ®Google Scholar
• MoodySEPerezDPanTCThe transcriptional repressor Snail promotes mammary tumor recurrenceCancer Cell20058319720916169465
   PubMed Web of Science ®Google Scholar
• GuoWKeckesovaZDonaherJLSlug and Sox9 cooperatively determine the mammary stem cell stateCell201214851015102822385965
   PubMed Web of Science ®Google Scholar
• RiazMSieuwertsAMLookMPHigh TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genesBreast Cancer Res201214R12322967435
   PubMed Web of Science ®Google Scholar
• MarkiewiczAAhrendsTWelnicka-JaśkiewiczMExpression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancerJ Transl Med20121022623157797
   PubMed Web of Science ®Google Scholar
• ScheelCWeinbergRACancer stem cells and epithelial-mesenchymal transition: concepts and molecular linksSemin Cancer Biol2012225–639640322554795
   PubMed Web of Science ®Google Scholar
• MayCDSphyrisNEvansKWWerdenSJGuoWManiSAEpithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progressionBreast Cancer Res20111320221392411
   PubMed Web of Science ®Google Scholar
• PapadakiMAKallergiGZafeiriouZCo-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancerBMC Cancer20141465125182808
   PubMed Web of Science ®Google Scholar
• Aguirre-GamboaRGomez-RuedaHMartinez-LedesmaESurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysisPLoS One201389e7425024066126
   PubMed Web of Science ®Google Scholar